Citations (110)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (24)
Aksam Yassin, Daniel Kelly, Joanne Nettleship, Raidh Talib, Raed M. Al-Zoubi, Omar M. Aboumarzouk & Bassam Albaba. (2023) Testosterone treatment and change of categories of the International prostate symptom score (IPSS) in hypogonadal patients: 12 years prospective controlled registry study. The Aging Male 26:1.
Read now
Read now
Bruno Lunenfeld, George Mskhalaya, Michael Zitzmann, Giovanni Corona, Stefan Arver, Svetlana Kalinchenko, Yuliya Tishova & Abraham Morgentaler. (2021) Recommendations on the diagnosis, treatment and monitoring of testosterone deficiency in men. The Aging Male 24:1, pages 119-138.
Read now
Read now
Yang Xiong, Yangchang Zhang, Xiaoyu Li, Feng Qin & Jiuhong Yuan. (2020) The prevalence and associated factors of lower urinary tract symptoms suggestive of benign prostatic hyperplasia in aging males. The Aging Male 23:5, pages 1432-1439.
Read now
Read now
Tsukasa Narukawa, Jintetsu Soh, Noriyuki Kanemitsu, Shunji Harikai & Osamu Ukimura. (2020) Efficacy of combined treatment of intramuscular testosterone injection and testosterone ointment application for late-onset hypogonadism: an open-labeled, randomized, crossover study. The Aging Male 23:5, pages 1059-1065.
Read now
Read now
Regina Carmen Espósito, Paulo José Medeiros, José Hipólito Dantas Júnior, Antonio Gouveia Oliveira, Sueli Aparecida Moreira & Valéria Soraya de Farias Sales. (2020) Blue November Campaign as an annual male self-care strategy for healthy aging. The Aging Male 23:5, pages 865-872.
Read now
Read now
Yoshihisa Matsukawa, Yoshie Kanada, Shun Takai, Satoshi Inoue, Tsuyoshi Majima, Yasuhito Funahashi, Masashi Kato, Tokunori Yamamoto & Momokazu Gotoh. (2020) Pre-treatment serum testosterone level can be a useful factor to predict the improvement in bladder outlet obstruction by tadalafil for male patients with lower urinary tract symptoms induced by benign prostatic obstruction. The Aging Male 23:5, pages 641-647.
Read now
Read now
Subo Qian, Xujun Sheng, Ding Xu, Haibo Shen, Jun Qi & Yu Wu. (2020) Variation of prostatic morphology in Chinese benign prostatic hyperplasia patients of different age decades. The Aging Male 23:5, pages 457-463.
Read now
Read now
Yuki Kato, Kazuyoshi Shigehara, Kazufumi Nakashima, Masashi Iijima, Shohei Kawagushi, Takahiro Nohara, Kouji Izumi, Yoshifumi Kadono, Hiroyuki Konaka, Mikio Namiki & Atsushi Mizokami. (2020) The five-year effects of testosterone replacement therapy on lipid profile and glucose tolerance among hypogonadal men in Japan: a case control study. The Aging Male 23:1, pages 23-28.
Read now
Read now
Ding Xu, Yu Wu, Haibo Shen, Subo Qian & Jun Qi. (2020) High serum concentration of estradiol may be a risk factor of prostate enlargement in aging male in China . The Aging Male 23:1, pages 1-6.
Read now
Read now
Toshiyasu Amano, Teruaki Iwamoto, Yoshikazu Sato, Tetsuya Imao & Carolyn Earle. (2018) The efficacy and safety of short-acting testosterone ointment (Glowmin) for late-onset hypogonadism in accordance with testosterone circadian rhythm. The Aging Male 21:3, pages 170-175.
Read now
Read now
Kazuyoshi Shigehara, Hiroyuki Konaka, Kazuhiro Sugimoto, Takahiro Nohara, Koji Izumi, Yoshifumi Kadono, Mikio Namiki & Atsushi Mizokami. (2018) Sleep disturbance as a clinical sign for severe hypogonadism: efficacy of testosterone replacement therapy on sleep disturbance among hypogonadal men without obstructive sleep apnea. The Aging Male 21:2, pages 99-105.
Read now
Read now
Toshiyasu Amano, Carolyn Earle, Tetsuya Imao, Yuki Matsumoto & Takahiro Kishikage. (2018) Administration of daily 5 mg tadalafil improves endothelial function in patients with benign prostatic hyperplasia. The Aging Male 21:1, pages 77-82.
Read now
Read now
Huseyin Besiroglu, Emin Ozbek, Murat Dursun & Alper Otunctemur. (2018) Visceral adiposity index is associated with benign prostatic enlargement in non-diabetic patients: a cross-sectional study. The Aging Male 21:1, pages 40-47.
Read now
Read now
Ozan Efesoy, Duygu Apa, Mesut Tek & Selahittin Çayan. (2016) The effect of testosterone treatment on prostate histology and apoptosis in men with late-onset hypogonadism. The Aging Male 19:2, pages 79-84.
Read now
Read now
Kazuyoshi Shigehara, Tohru Miyagi, Takao Nakashima, Koji Izumi, Yasuhide Kitagawa, Atsushi Mizokami, Eitetsu Koh, Masayoshi Shimamura & Mikio Namiki. (2016) Effects of dutasteride on lower urinary tract symptoms: a prospective analysis based on changes in testosterone/dihydrotestosterone levels and total prostatic volume reduction. The Aging Male 19:2, pages 128-133.
Read now
Read now
Toshiyasu Amano, Carolyn Earle, Tetsuya Imao & Katsuro Takemae. (2016) Are urge incontinence and aging risk factors of erectile dysfunction in patients with male lower urinary tract symptoms?. The Aging Male 19:1, pages 54-57.
Read now
Read now
Michał Rabijewski, Lucyna Papierska, Roman Kuczerowski & Paweł Piątkiewicz. (2015) Hormonal determinants of erectile dysfunction and lower urinary tract symptoms in middle-aged and elderly men with prediabetes. The Aging Male 18:4, pages 256-264.
Read now
Read now
Giorgio Ivan Russo, Tommaso Castelli, Daniele Urzì, Salvatore Privitera, Eugenia Fragalà, Sandro La Vignera, Rosita A. Condorelli, Aldo E. Calogero, Vincenzo Favilla, Sebastiano Cimino & Giuseppe Morgia. (2015) Connections between lower urinary tract symptoms related to benign prostatic enlargement and metabolic syndrome with its components: a systematic review and meta-analysis. The Aging Male 18:4, pages 207-216.
Read now
Read now
Kazuyoshi Shigehara, Hiroyuki Konaka, Eitetsu Koh, Koji Izumi, Yasuhide Kitagawa, Atsushi Mizokami, Takao Nakashima, Masayoshi Shimamura, Teruaki Iwamoto & Mikio Namiki. (2015) Effects of testosterone replacement therapy on nocturia and quality of life in men with hypogonadism: a subanalysis of a previous prospective randomized controlled study in Japan. The Aging Male 18:3, pages 169-174.
Read now
Read now
Bruno Lunenfeld, George Mskhalaya, Michael Zitzmann, Stefan Arver, Svetlana Kalinchenko, Yuliya Tishova & Abraham Morgentaler. (2015) Recommendations on the diagnosis, treatment and monitoring of hypogonadism in men. The Aging Male 18:1, pages 5-15.
Read now
Read now
Keisuke Okada, Kohei Yamaguchi, Koji Chiba, Hideaki Miyake & Masato Fujisawa. (2014) Comprehensive evaluation of androgen replacement therapy in aging Japanese men with late-onset hypogonadism. The Aging Male 17:2, pages 72-75.
Read now
Read now
Kazuyoshi Shigehara, Eitetsu Koh, Jiro Sakamoto, Hiroshi Yaegashi, Koji Izumi, Satoru Ueno, Yasuhide Kitagawa, Yuji Maeda, Yoshifumi Kadono, Hiroyuki Konaka, Atsushi Mizokami, Takao Nakashima & Mikio Namiki. (2014) Effects of dutasteride on lower urinary tract symptoms and general health in men with benign prostatic hypertroplasia and hypogonadism: a prospective study. The Aging Male 17:1, pages 51-56.
Read now
Read now
Bruno Lunenfeld, George Mskhalaya, Svetlana Kalinchenko & Yulia Tishova. (2013) Recommendations on the diagnosis, treatment and monitoring of late-onset hypogonadism in men – a suggested update. The Aging Male 16:4, pages 143-150.
Read now
Read now
Steven A. Kaplan, Edward O’Neill, Robert Lowe, Mary Hanson & Alan G. Meehan. (2013) Prevalence of low testosterone in aging men with benign prostatic hyperplasia: data from the Proscar Long-term Efficacy and Safety Study (PLESS). The Aging Male 16:2, pages 48-51.
Read now
Read now
Articles from other publishers (86)
L. Lin, W. Wang, K. Xiao, X. Guo & L. Zhou. (2023) Genetically elevated bioavailable testosterone level was associated with the occurrence of benign prostatic hyperplasia. Journal of Endocrinological Investigation.
Crossref
Crossref
Tae Yong Park, Moon Young Choi, Dong Soo Kim, Jeong Kyun Yeo, Mahadevan Rajasekaran & Min Gu Park. (2023) Correlation Analysis between Hypogonadal Symptoms and Changes in Body Composition and Physical Fitness after Testosterone Treatment in Men with Testosterone Deficiency. The World Journal of Men's Health 41.
Crossref
Crossref
Takamitsu Tsuru, Akira Tsujimura, Kazuhiko Mizushima, Makoto Kurosawa, Akimasa Kure, Yuka Uesaka, Taiji Nozaki, Masato Shirai, Kazuhiro Kobayashi & Shigeo Horie. (2023) International Prostate Symptom Score and Quality of Life Index for Lower Urinary Tract Symptoms Are Associated with Aging Males Symptoms Rating Scale for Late-Onset Hypogonadism Symptoms. The World Journal of Men's Health 41:1, pages 101.
Crossref
Crossref
Karin Welén & Jan-Erik Damber. (2022) Androgens, aging, and prostate health. Reviews in Endocrine and Metabolic Disorders 23:6, pages 1221-1231.
Crossref
Crossref
Bin Zeng, Shi Qiu, Xingyu Xiong, Xingyang Su, Zilong Zhang, Qiang Wei & Lu Yang. (2022) The effect of different administrations of testosterone therapy on adverse prostate events: A Bayesian network meta-analysis. Frontiers in Endocrinology 13.
Crossref
Crossref
A. M. Isidori, A. Aversa, A. Calogero, A. Ferlin, S. Francavilla, F. Lanfranco, R. Pivonello, V. Rochira, G. Corona & M. Maggi. (2022) Adult- and late-onset male hypogonadism: the clinical practice guidelines of the Italian Society of Andrology and Sexual Medicine (SIAMS) and the Italian Society of Endocrinology (SIE). Journal of Endocrinological Investigation 45:12, pages 2385-2403.
Crossref
Crossref
Min Ho Lee, Yu Seob Shin & Sung Chul Kam. (2021) Correlation Between Testosterone Replacement Treatment and Lower Urinary Tract Symptoms. International Neurourology Journal 25:1, pages 12-22.
Crossref
Crossref
Rossella Cannarella, Rosita A. Condorelli, Federica Barbagallo, Sandro La Vignera & Aldo E. Calogero. (2021) Endocrinology of the Aging Prostate: Current Concepts. Frontiers in Endocrinology 12.
Crossref
Crossref
Zhichao Zhang, Deying Kang & Hongjun Li. (2020) The effects of testosterone on bone health in males with testosterone deficiency: a systematic review and meta-analysis. BMC Endocrine Disorders 20:1.
Crossref
Crossref
Eduardo P. Miranda & Luiz Otávio Torres. (2020) Late‐onset hypogonadism: Prostate safety. Andrology 8:6, pages 1606-1613.
Crossref
Crossref
Susan J. DiemNancy L. GreerRoderick MacDonaldLauren G. McKenziePhilipp DahmNacide Ercan-FangAllison EstradaLaura S. HemmyChristina E. RosebushHoward A. FinkTimothy J. Wilt. (2020) Efficacy and Safety of Testosterone Treatment in Men: An Evidence Report for a Clinical Practice Guideline by the American College of Physicians. Annals of Internal Medicine 172:2, pages 105.
Crossref
Crossref
Omar Seyam, Jason Gandhi, Gunjan Joshi, Noel L. Smith & Sardar Ali Khan. (2019) Obesity’s role in secondary male hypogonadism: a review of pathophysiology and management issues. SN Comprehensive Clinical Medicine 1:6, pages 408-418.
Crossref
Crossref
JJ H. Zhang, Bradley A. Gill, Lamont Wilkins, Rathika R. Ramkumar & Daniel A. Shoskes. (2019) Systemic Comorbidity Burden Using the ACTIONS Phenotype Predicts Urologic Medication Discontinuation Following Transurethral Resection of the Prostate. Urology 127, pages 91-96.
Crossref
Crossref
Sevann Helo, Peyton Thomas & Nicholas N. Tadros. (2019) Testosterone and male rejuvenation. Panminerva Medica 61:2.
Crossref
Crossref
Giulia Rastrelli, Linda Vignozzi, Giovanni Corona & Mario Maggi. (2019) Testosterone and Benign Prostatic Hyperplasia. Sexual Medicine Reviews 7:2, pages 259-271.
Crossref
Crossref
Min Park, Jeong Yeo, Sun Park, Woong Na & Du Moon. (2019) Predictive Factors of Efficacy Maintenance after Testosterone Treatment Cessation. Journal of Clinical Medicine 8:2, pages 151.
Crossref
Crossref
James Anaissie, Alexander W. Pastuszak & Mohit Khera. 2019. Effects of Lifestyle on Men's Health. Effects of Lifestyle on Men's Health
235
251
.
Abdulmaged M. Traish & Abraham Morgentaler. 2019. Sex Differences in Cardiovascular Physiology and Pathophysiology. Sex Differences in Cardiovascular Physiology and Pathophysiology
321
354
.
Ji S. SHIM, Jae H. KIM, Yong S. YOON, Hoon CHOI, Jae Y. PARK & Jae H. BAE. (2018) Serum Testosterone Levels Are Negatively Correlated with International Prostate Symptom Score and Transitional Prostate Volume. LUTS: Lower Urinary Tract Symptoms 10:2, pages 143-147.
Crossref
Crossref
Farid Saad, Gheorghe DorosKarim Sultan HaiderAhmad Haider. (2018) Hypogonadal men with moderate-to-severe lower urinary tract symptoms have a more severe cardiometabolic risk profile and benefit more from testosterone therapy than men with mild lower urinary tract symptoms. Investigative and Clinical Urology 59:6, pages 399.
Crossref
Crossref
Abdulmaged M. Traish. (2018) Benefits and Health Implications of Testosterone Therapy in Men With Testosterone Deficiency. Sexual Medicine Reviews 6:1, pages 86-105.
Crossref
Crossref
Karim Sultan Haider, Ahmad Haider, Gheorghe Doros & Abdulmaged Traish. (2018) Long-Term Testosterone Therapy Improves Urinary and Sexual Function, and Quality of Life in Men with Hypogonadism: Results from a Propensity Matched Subgroup of a Controlled Registry Study. Journal of Urology 199:1, pages 257-265.
Crossref
Crossref
Mauro Gacci, Arcangelo Sebastianelli & Matteo Salvi. 2018. Lower Urinary Tract Symptoms and Benign Prostatic Hyperplasia. Lower Urinary Tract Symptoms and Benign Prostatic Hyperplasia
89
111
.
Abraham Morgentaler. (2017) The Testosterone Trials: What the Results Mean for Healthcare Providers and for Science. Current Sexual Health Reports 9:4, pages 290-295.
Crossref
Crossref
Mamoru HASHIMOTO, Nobutaka SHIMIZU, Koichi SUGIMOTO, Sachiko HONGOH, Takafumi MINAMI, Masahiro NOZAWA, Kazuhiro YOSHIMURA, Akihide HIRAYAMA, Hideo TAHARA & Hirotsugu UEMURA. (2017) Efficacy of Adding Dutasteride to α-Blocker Therapy Treated Benign Prostatic Hyperplasia Patients with Small Volume Prostate (<30 mL). LUTS: Lower Urinary Tract Symptoms 9:3, pages 157-160.
Crossref
Crossref
Faysal A. Yafi, Nora M. Haney, James Anaissie, Kenneth J. DeLay, Landon Trost, Mohit Khera & Wayne J.G. Hellstrom. (2017) Practice Patterns in the Diagnosis and Management of Hypogonadism: A Survey of Sexual Medicine Society of North America Members. Urology 106, pages 87-95.
Crossref
Crossref
Amin S. Herati, Taylor P. Kohn, Peter R. Butler & Larry I. Lipshultz. (2017) Effects of Testosterone on Benign and Malignant Conditions of the Prostate. Current Sexual Health Reports 9:2, pages 65-73.
Crossref
Crossref
Grace E. Kohn, Taylor P. Kohn & Ranjith Ramasamy. (2017) Effects of Testosterone Replacement Therapy on Lower Urinary Tract Symptoms. Current Bladder Dysfunction Reports 12:2, pages 118-123.
Crossref
Crossref
Kazuyoshi ShigeharaKoji IzumiAtsushi MizokamiMikio Namiki. (2017) Testosterone Deficiency and Nocturia: A Review. The World Journal of Men's Health 35:1, pages 14.
Crossref
Crossref
Kouji Izumi, Kazuyoshi Shigehara, Takahiro Nohara, Kazutaka Narimoto, Yoshifumi Kadono, Shigeki Nanjo, Tadaaki Yamada, Koushiro Ohtsubo, Seiji Yano & Atsushi Mizokami. (2017) Androgen replacement therapy for cancer-related symptoms in male advanced cancer patients: study protocol for a randomised prospective trial (ARTFORM study). The Journal of Medical Investigation 64:3.4, pages 202-204.
Crossref
Crossref
N. Enatsu, H. Miyake, T. Haraguchi, K. Chiba & M. Fujisawa. (2016) Effects of dutasteride on serum free-testosterone and clinical significance of testosterone changes. Andrologia 48:10, pages 1195-1201.
Crossref
Crossref
Mohit Khera, Ganesh Adaikan, Jacques Buvat, Serge Carrier, Amr El-Meliegy, Kostas Hatzimouratidis, Andrew McCullough, Abraham Morgentaler, Luiz Otavio Torres & Andrea Salonia. (2016) Diagnosis and Treatment of Testosterone Deficiency: Recommendations From the Fourth International Consultation for Sexual Medicine (ICSM 2015). The Journal of Sexual Medicine 13:12, pages 1787-1804.
Crossref
Crossref
Kenneth Jackson DeLay & Tobias S. Kohler. (2016) Testosterone and the Prostate. Urologic Clinics of North America 43:3, pages 405-412.
Crossref
Crossref
Mohit Khera, Gregory A. Broderick, Culley C. CarsonIIIIII, Adrian S. Dobs, Martha M. Faraday, Irwin Goldstein, Lawrence S. Hakim, Wayne J.G. Hellstrom, Ravi Kacker, Tobias S. Köhler, Jesse N. Mills, Martin Miner, Hossein Sadeghi-Nejad, Allen D. Seftel, Ira D. Sharlip, Stephen J. Winters & Arthur L. Burnett. (2016) Adult-Onset Hypogonadism. Mayo Clinic Proceedings 91:7, pages 908-926.
Crossref
Crossref
William J. Huang. (2016) Hypogonadism and voiding dysfunction in men. Urological Science 27:2, pages 53-55.
Crossref
Crossref
Taylor P. Kohn, Douglas A. Mata, Ranjith Ramasamy & Larry I. Lipshultz. (2016) Effects of Testosterone Replacement Therapy on Lower Urinary Tract Symptoms: A Systematic Review and Meta-analysis. European Urology 69:6, pages 1083-1090.
Crossref
Crossref
S. La Vignera, R. A. Condorelli, G. I. Russo, G. Morgia & A. E. Calogero. (2016) Endocrine control of benign prostatic hyperplasia. Andrology 4:3, pages 404-411.
Crossref
Crossref
CHANGCHENG GUO, WENYU GU, MIN LIU, BO PENG, XUDONG YAO, BIN YANG & JUNHUA ZHENG. (2016) Efficacy and safety of testosterone replacement therapy in men with hypogonadism: A meta-analysis study of placebo-controlled trials. Experimental and Therapeutic Medicine 11:3, pages 853-863.
Crossref
Crossref
Mohit Khera. (2016) Male hormones and men's quality of life. Current Opinion in Urology 26:2, pages 152-157.
Crossref
Crossref
Fouad Aoun, Anthony Kallas Chemaly, Simone Albisinni, Marc Zanaty & Thierry Roumeguere. (2016) In Search for a Common Pathway for Health Issues in Men - the Sign of a Holmesian Deduction. Asian Pacific Journal of Cancer Prevention 17:1, pages 1-13.
Crossref
Crossref
J. Abram McBride, Culley C. CarsonIIIIII & Robert M. Coward. (2015) Testosterone deficiency in the aging male. Therapeutic Advances in Urology 8:1, pages 47-60.
Crossref
Crossref
Linda Vignozzi, Mauro Gacci & Mario Maggi. (2016) Lower urinary tract symptoms, benign prostatic hyperplasia and metabolic syndrome. Nature Reviews Urology 13:2, pages 108-119.
Crossref
Crossref
Yoshihisa Matsukawa, Shun Takai, Yasuhito Funahashi, Masashi Kato, Tokunori Yamamoto, Akihiro Hirakawa & Momokazu Gotoh. (2016) The Change of Testosterone Secretion During the Treatment of Alpha-1 Blocker in Patients with Benign Prostatic Hyperplasia. Urology 88, pages 149-154.
Crossref
Crossref
Martin Kathrins, Karen Doersch, Tony Nimeh, Arturo Canto, Craig Niederberger & Allen Seftel. (2016) The Relationship Between Testosterone-Replacement Therapy and Lower Urinary Tract Symptoms: A Systematic Review. Urology 88, pages 22-32.
Crossref
Crossref
Abdulmaged Traish. (2016) Testosterone therapy in men with testosterone deficiency: Are we beyond the point of no return?. Investigative and Clinical Urology 57:6, pages 384.
Crossref
Crossref
Joel J. Heidelbaugh, Anthony Grech & Martin M. Miner. 2016. Men's Health in Primary Care. Men's Health in Primary Care
249
267
.
Shin-ichi Hisasue. (2015) Contemporary perspective and management of testosterone deficiency: Modifiable factors and variable management. International Journal of Urology 22:12, pages 1084-1095.
Crossref
Crossref
John D. Dean, Chris G. McMahon, Andre T. Guay, Abraham Morgentaler, Stanley E. Althof, Edgardo F. Becher, Trinity J. Bivalacqua, Arthur L. Burnett, Jacques Buvat, Amr El Meliegy, Wayne J.G. Hellstrom, Emmanuele A. Jannini, Mario Maggi, Andrew McCullough, Luiz Otavio Torres & Michael Zitzmann. (2015) The International Society for Sexual Medicine's Process of Care for the Assessment and Management of Testosterone Deficiency in Adult Men. The Journal of Sexual Medicine 12:8, pages 1660-1686.
Crossref
Crossref
Ryan C. Owen, Osama O. Elkelany & Edward D. Kim. (2015) Testosterone supplementation in men. Current Opinion in Obstetrics & Gynecology 27:4, pages 258-264.
Crossref
Crossref
Aaron Moore, Michael J. Butcher & Tobias S. Köhler. (2015) Testosterone Replacement Therapy on the Natural History of Prostate Disease. Current Urology Reports 16:8.
Crossref
Crossref
R. Kacker, V. Harisaran, L. Given, M. Miner, R. Rittmaster & A. Morgentaler. (2015) Dutasteride in men receiving testosterone therapy: a randomised, double-blind study. Andrologia 47:2, pages 148-152.
Crossref
Crossref
De-Ying Kang & Hong-Jun Li. (2015) The Effect of Testosterone Replacement Therapy on Prostate-Specific Antigen (PSA) Levels in Men Being Treated for Hypogonadism. Medicine 94:3, pages e410.
Crossref
Crossref
Lluís Bassas & Eugenia Resmini. 2015. PanVascular Medicine. PanVascular Medicine
4681
4693
.
Anthony Grech, John Breck & Joel Heidelbaugh. (2014) Adverse effects of testosterone replacement therapy: an update on the evidence and controversy. Therapeutic Advances in Drug Safety 5:5, pages 190-200.
Crossref
Crossref
Ronny B.W. Tan, Jonathan L. Silberstein & Wayne J.G. Hellstrom. (2014) Testosterone and the Prostate. Sexual Medicine Reviews 2:3-4, pages 112-120.
Crossref
Crossref
Kazuyoshi SHIGEHARA, Kazuhiro SUGIMOTO, Hiroyuki KONAKA, Yuji MAEDA, Yasuhide KITAGAWA, Atsushi MIZOKAMI, Eitetsu KOH & Mikio NAMIKI. (2014) Lower Urinary Tract Symptoms are Associated with Erectile Function and Psychological Symptoms in Men with Late-Onset Hypogonadism Syndrome. LUTS: Lower Urinary Tract Symptoms 6:3, pages 151-156.
Crossref
Crossref
Y Cui, H Zong, H Yan & Y Zhang. (2014) The effect of testosterone replacement therapy on prostate cancer: a systematic review and meta-analysis. Prostate Cancer and Prostatic Diseases 17:2, pages 132-143.
Crossref
Crossref
Udi Blankstein, Bilal Chughtai & Dean S. Elterman. (2014) Relationship Between the Metabolic Syndrome and BPH-Related Voiding Dysfunction. Current Bladder Dysfunction Reports 9:2, pages 122-128.
Crossref
Crossref
Jun Ho Lee, Yooseok Kim, Yeon Won Park & Dong-Gi Lee. (2014) Relationship Between Benign Prostatic Hyperplasia/Lower Urinary Tract Symptoms and Total Serum Testosterone Level in Healthy Middle-Aged Eugonadal Men. The Journal of Sexual Medicine 11:5, pages 1309-1315.
Crossref
Crossref
L. Vignozzi, G. Rastrelli, G. Corona, M. Gacci, G. Forti & M. Maggi. (2014) Benign prostatic hyperplasia: a new metabolic disease?. Journal of Endocrinological Investigation 37:4, pages 313-322.
Crossref
Crossref
Geoffrey Hackett, Nigel Cole, Mithun Bhartia, David Kennedy, Jessie Raju, Peter Wilkinson & the BLAST Study Group. (2014) Testosterone Replacement Therapy Improves Metabolic Parameters in Hypogonadal Men with Type 2 Diabetes but Not in Men with Coexisting Depression: The BLAST Study. The Journal of Sexual Medicine 11:3, pages 840-856.
Crossref
Crossref
R. A. Condorelli, A. E. Calogero, E. Vicari, V. Favilla, S. Cimino, G. I. Russo, G. Morgia & S. La Vignera. (2014) Male Accessory Gland Infection: Relevance of Serum Total Testosterone Levels. International Journal of Endocrinology 2014, pages 1-6.
Crossref
Crossref
Giovanni Corona, Linda Vignozzi, Giulia Rastrelli, Francesco Lotti, Sarah Cipriani & Mario Maggi. (2014) Benign Prostatic Hyperplasia: A New Metabolic Disease of the Aging Male and Its Correlation with Sexual Dysfunctions. International Journal of Endocrinology 2014, pages 1-14.
Crossref
Crossref
P. Comeglio, A. Morelli, I. Cellai, L. Vignozzi, E. Sarchielli, S. Filippi, E. Maneschi, F. Corcetto, C. Corno, M. Gacci, G.B. Vannelli & M. Maggi. (2014) Opposite effects of tamoxifen on metabolic syndrome-induced bladder and prostate alterations: A role for GPR30/GPER?. The Prostate 74:1, pages 10-28.
Crossref
Crossref
Ozan Bozkurt, Deniz Bolat, Omer Demir, Oktay Ucer, Ali Şahin, Burak Ozcift, Abdulkadir Pektaş, Tahir Turan, Bilal H Gümüş, Ertan Can, Ahmet Bolukbasi, Haluk Erol & Adil Esen. (2013) Erectile function and late-onset hypogonadism symptoms related to lower urinary tract symptom severity in elderly men. Asian Journal of Andrology 15:6, pages 785-789.
Crossref
Crossref
Yuanshan Cui & Yong Zhang. (2013) The Effect of Androgen-replacement Therapy on Prostate Growth: A Systematic Review and Meta-analysis. European Urology 64:5, pages 811-822.
Crossref
Crossref
Roberto Soler, Karl-Erik Andersson, Michael B. Chancellor, Christopher R. Chapple, William C. de Groat, Marcus J. Drake, Christian Gratzke, Richard Lee & Francisco Cruz. (2013) Future Direction in Pharmacotherapy for Non-neurogenic Male Lower Urinary Tract Symptoms. European Urology 64:4, pages 610-621.
Crossref
Crossref
Akira Komiya, Mika Kino, Tomonori Kato, Hiroyoshi Suzuki, Tomohiko Ichikawa & Hideki Fuse. (2013) Correlations Among Urinary, Sexual, and Testicular Functions and Health-Related Quality of Life. Journal of Men's Health 10:3, pages 112-118.
Crossref
Crossref
Geoffrey Hackett, Nigel Cole, Mithun Bhartia, David Kennedy, Jessie Raju & Peter Wilkinson. (2013) Testosterone Replacement Therapy with Long‒Acting Testosterone Undecanoate Improves Sexual Function and Quality‒of‒Life Parameters vs. Placebo in a Population of Men with Type 2 Diabetes. The Journal of Sexual Medicine 10:6, pages 1612-1627.
Crossref
Crossref
Wei Shen Tan, Wah Yun Low, Chirk Jenn Ng, Wei Keith Tan, Seng Fah Tong, Christopher Ho, Ee Ming Khoo, George Lee, Boon Cheok Lee, Verna Lee & Hui Meng Tan. (2013) Efficacy and safety of long‐acting intramuscular testosterone undecanoate in aging men: a randomised controlled study. BJU International 111:7, pages 1130-1140.
Crossref
Crossref
Linda Vignozzi, Mauro Gacci, Ilaria Cellai, Raffaella Santi, Giovanni Corona, Annamaria Morelli, Giulia Rastrelli, Paolo Comeglio, Arcangelo Sebastanelli, Elena Maneschi, Gabriella Nesi, Cosimo De Nunzio, Andrea Tubaro, Edoardo Mannucci, Marco Carini & Mario Maggi. (2012) Fat boosts, while androgen receptor activation counteracts, BPH‐associated prostate inflammation. The Prostate 73:8, pages 789-800.
Crossref
Crossref
C-S Lin, Z Xin, M Namiki, M Albersen, D Muller & T F Lue. (2013) Direct androgen regulation of PDE5 gene or the lack thereof. International Journal of Impotence Research 25:3, pages 81-85.
Crossref
Crossref
Young Hwii KoDu Geon MoonKi Hak Moon. (2013) Testosterone Replacement Alone for Testosterone Deficiency Syndrome Improves Moderate Lower Urinary Tract Symptoms: One Year Follow-Up. The World Journal of Men's Health 31:1, pages 47.
Crossref
Crossref
Jacques Buvat, Mario Maggi, André Guay & Luiz Otavio Torres. (2013) Testosterone Deficiency in Men: Systematic Review and Standard Operating Procedures for Diagnosis and Treatment. The Journal of Sexual Medicine 10:1, pages 245-284.
Crossref
Crossref
Ferenc G. Rick, Seyed H. Saadat, Luca Szalontay, Norman L. Block, Amir Kazzazi, Bob Djavan & Andrew V. Schally. (2013) Hormonal manipulation of benign prostatic hyperplasia. Current Opinion in Urology 23:1, pages 17-24.
Crossref
Crossref
Lluís Bassas & Eugenia Resmini. 2013. PanVascular Medicine. PanVascular Medicine
1
19
.
Peter T. K. Chan. 2013. Biennial Review of Infertility. Biennial Review of Infertility
31
48
.
A. Scott Polackwich, Kevin A. Ostrowski & Jason C. Hedges. (2012) Testosterone Replacement Therapy and Prostate Health. Current Urology Reports 13:6, pages 441-446.
Crossref
Crossref
Alexandra Oudot, Stéphanie Oger, Delphine Behr-Roussel, Stéphanie Caisey, Jacques Bernabé, Laurent Alexandre & François Giuliano. (2012) A new experimental rat model of erectile dysfunction and lower urinary tract symptoms associated with benign prostatic hyperplasia: the testosterone-supplemented spontaneously hypertensive rat. BJU International 110:9, pages 1352-1358.
Crossref
Crossref
Carla B. M. Gallo, Alexandre F. Miranda, Bruno Felix‐Patricio, Cristiane F. Ramos, Luiz E. M. Cardoso, Waldemar S. Costa & Francisco J. B. Sampaio. (2013) Effects of Castration and Hormone Replacement in the Urinary Bladder of Rats: Structural, Ultrastructural, and Biochemical Analysis. Journal of Andrology 33:4, pages 684-690.
Crossref
Crossref
Linda Vignozzi, Ilaria Cellai, Raffaella Santi, Letizia Lombardelli, Annamaria Morelli, Paolo Comeglio, Sandra Filippi, Federica Logiodice, Marco Carini, Gabriella Nesi, Mauro Gacci, Marie-Pierre Piccinni, Luciano Adorini & Mario Maggi. (2012) Antiinflammatory effect of androgen receptor activation in human benign prostatic hyperplasia cells. Journal of Endocrinology 214:1, pages 31-43.
Crossref
Crossref
. (2012) Current World Literature. Current Opinion in Endocrinology, Diabetes & Obesity 19:3, pages 233-247.
Crossref
Crossref
Linda Vignozzi, Annamaria Morelli, Erica Sarchielli, Paolo Comeglio, Sandra Filippi, Ilaria Cellai, Elena Maneschi, Sergio Serni, Mauro Gacci, Marco Carini, Marie-Pierre Piccinni, Farid Saad, Luciano Adorini, Gabriella B Vannelli & Mario Maggi. (2012) Testosterone protects from metabolic syndrome-associated prostate inflammation: an experimental study in rabbit. Journal of Endocrinology 212:1, pages 71-84.
Crossref
Crossref
Chun-Hou Liao, Han-Sun Chiang & Po-Jen Hsiao. (2011) Lower urinary tract symptoms and erectile dysfunction. Urological Science 22:4, pages 135-140.
Crossref
Crossref
Farid SaadLouis J Gooren. (2011) Late Onset Hypogonadism and Lower Urinary Tract Symptoms: New Insights. Korean Journal of Andrology 29:1, pages 1.
Crossref
Crossref
Kazuyoshi ShigeharaMikio Namiki. (2011) Late-Onset Hypogonadism Syndrome and Lower Urinary Tract Symptoms. Korean Journal of Urology 52:10, pages 657.
Crossref
Crossref